Atlas Trials

Lymphocytic Leukemia

13 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Lymphocytic Leukemia

RecordFirmDate
A Study to Investigate the Efficacy and Safety of MS-553 in CLL/SLL (NCT05272813)Shenzhen MingSight Relin Pharmaceuticals Co., Ltd.2022-04-28
Duvelisib in Combination With BMS-986345 in Lymphoid Malignancy (NCT05065866)H. Lee Moffitt Cancer Center and Research Institute2021-11-18
Symbenda Post-Marketing Surveillance (PMS) (NCT02434484)Eisai Korea Inc.2018-07-04
A Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Treatment-naive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (NCT02556892)Janssen Pharmaceutical K.K.2015-07-03
Lirilumab With Rituximab for Relapsed, Refractory or High-risk Untreated Chronic Lymphocytic Leukemia (CLL) Patients (NCT02481297)M.D. Anderson Cancer Center2015-06-23
Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT00935792)Mayo Clinic2009-07-01
Lenalidomide in Comb w/Rituximab for Pts w/CD5+/CD20+ Hem Malignancies Who Relapse/Progress After Rituximab (NCT00609869)H. Lee Moffitt Cancer Center and Research Institute2007-10-01
This Study is Being Performed to Evaluate the Effect of Genasense on the Efficacy and the Safety of Rituximab/Fludarabine Combination Treatment in Previously Untreated Subjects With Chronic Lymphocyctic Leukemia(CLL) (NCT00517218)Genta Incorporated2006-06-01
Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies (NCT00013533)National Cancer Institute (NCI)2001-03-14
Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies (NCT01499147)University of Illinois at Chicago2000-02-01

Track Lymphocytic Leukemia automatically

Every clearance here is in the API, with alerts when new ones post.